Detalhe da pesquisa
1.
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
Lancet Oncol
; 25(4): 518-528, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547895
2.
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
Int J Cancer
; 154(3): 504-515, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37908048
3.
Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1).
Int J Cancer
; 148(3): 682-691, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33405269
4.
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
BMC Cancer
; 20(1): 352, 2020 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32334548
5.
Infiltrating and peripheral immune cell analysis in advanced gastric cancer according to the Lauren classification and its prognostic significance.
Gastric Cancer
; 23(1): 73-81, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31267360
6.
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 19(8): 1094-1106, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30042063
7.
Colorectal Cancer in People with Intellectual Disabilities.
Oncology
; 95(6): 323-336, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30173217
8.
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
BMC Cancer
; 17(1): 574, 2017 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28841909
9.
First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control.
Oncology
; 90(2): 88-96, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26784946
10.
TAS-118 plus oxaliplatin in advanced gastric cancer: is it worth it?
Lancet Oncol
; 21(8): 1002-1003, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32682456
11.
Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort.
Gastric Cancer
; 17(2): 341-7, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23739764
12.
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients.
Dig Liver Dis
; 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38233313
13.
The role of the FOLFIRINOX regimen for advanced pancreatic cancer.
Curr Oncol Rep
; 15(2): 182-9, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23341367
14.
Treatment of gastric adenocarcinoma: A rapidly evolving landscape.
Eur J Cancer
; 195: 113370, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37948843
15.
DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study.
Exp Hematol Oncol
; 12(1): 63, 2023 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37480095
16.
Perioperative FOLFOX in Patients With Locally Advanced Oesogastric Adenocarcinoma.
Anticancer Res
; 42(1): 185-193, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34969724
17.
Economic evaluation of encorafenib with cetuximab in patients with BRAF V600E-mutant metastatic colorectal cancer in France: a cost-effectiveness analysis using data from the BEACON CRC randomised controlled trial.
BMJ Open
; 12(11): e063700, 2022 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36410812
18.
The desmoplastic growth pattern is associated with second-stage completion and longer survival in 2-stage hepatectomy for colorectal cancer liver metastases.
Surgery
; 172(5): 1434-1441, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36089423
19.
Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study.
Adv Ther
; 39(6): 2731-2748, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35419649
20.
SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancer.
Dig Liver Dis
; 54(6): 747-754, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35351371